Abstract
Despite extensive studies on CD4 + CD25 + regulatory T cells (Tregs) during the past decade, the progress on their clinical translation remains stagnant. Mounting evidence suggests that naturally occurring CD8 + CD122 + T cells are also Tregs with the capacity to inhibit T-cell responses and suppress autoimmunity as well as alloimmunity. In fact, they are memory-like Tregs that resemble a central memory T cell (T CM) phenotype. The mechanisms underlying their suppression are still not well understood, although they may include IL-10 production. We have recently demonstrated that programmed death-1 (PD-1) expression distinguishes between regulatory and memory CD8 + CD122 + T cells and that CD8 + CD122 + Tregs undergo faster homeostatic proliferation and are more potent in the suppression of allograft rejection than conventional CD4 + CD25 + Tregs. These findings may open a new line of investigation for accelerating effective Treg therapies in the clinic. In this review, we summarize the significant progress in this promising field of CD8 + CD122 + Treg research and discuss their phenotypes, suppressive roles in autoimmunity and alloimmunity, functional requirements, mechanisms of action and potential applications in the clinic.
Original language | English (US) |
---|---|
Pages (from-to) | 326-331 |
Number of pages | 6 |
Journal | Cellular and Molecular Immunology |
Volume | 11 |
Issue number | 4 |
DOIs | |
State | Published - Jul 2014 |
Keywords
- autoimmunity and transplant immunology
- immune regulation
- regulatory T cells
ASJC Scopus subject areas
- Immunology and Allergy
- Infectious Diseases
- Immunology